Andreas Lind Selected Research

Andreas Lind Research Topics

4	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2020
3	COVID-19 01/2022 - 10/2020
3	Disease Progression 01/2016 - 07/2011
3	HIV Infections (HIV Infection) 08/2015 - 07/2011
2	Infections 02/2021 - 07/2011
2	Hypersensitivity (Allergy) 09/2013 - 08/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Thrombotic Microangiopathies 02/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Hypercapnia 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2015
1	Persistent Infection 01/2014

3	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 02/2021 - 10/2020
2	CytokinesIBA 12/2020 - 09/2013
2	AntigensIBA 01/2016 - 01/2014
2	VaccinesIBA 01/2016 - 07/2011
2	Vacc-4xIBA 09/2013 - 08/2012
1	InterferonsIBA 01/2022
1	Complement Factor B (Factor B)IBA 02/2021
1	eculizumab FDA Link 02/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Chemotactic FactorsIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Complement Inactivating AgentsIBA 10/2020
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2020
1	AIDS VaccinesIBA 09/2013
1	ChemokinesIBA 09/2013
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 09/2013
1	Granzymes (Granzyme)IBA 09/2013
1	HMGB1 Protein (HMG1)IBA 06/2013
1	LipopolysaccharidesIBA 07/2011
1	Celecoxib (Celebrex)FDA Link 07/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2011
1	Cyclic AMP (AMP, Cyclic)IBA 07/2011
1	ProstaglandinsIBA 07/2011